Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic cancer and its prognostic significance

doi:10.4251/wjgo.v17.i9.109055

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

(44)

(49)

(0)

(12)

(1039)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109055
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109055

Table 1 Clinicopathologic characteristics of patients with pancreatic cancer

Characteristic	Total number (n = 93)
Age (years)	< 60: 21	≥ 60: 72
Sex	Male: 43	Female: 50
Tumor location	Head: 68	Body or tail: 25
Stage	RPC: 67	BRPC: 26
Lymph node	Negative: 19	Positive: 74
RM	Negative: 61	Positive: 32
Adjuvant therapy	None: 41	Yes: 52
CA 19-9	< 150 U/mL: 49	≥ 150 U/mL: 44
Histology	PD: 16	WD/MD/others: 77

RM: Resection margin; CA 19-9: Carbohydrate antigen 19-9; RPC: Resectable pancreatic cancer; BRPC: Borderline resectable pancreatic cancer; PD: Poorly differentiated; WD: Well differentiated; MD: Moderately differentiated.

Full Size Table

Citation: Kim JH, Na HY, Jung K, Jang D, Youn Y, Kim DH, Han HD, Hwang JH. Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic cancer and its prognostic significance. World J Gastrointest Oncol 2025; 17(9): 109055
URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109055.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109055

Kim JH, Na HY, Jung K, Jang D, Youn Y, Kim DH, Han HD, Hwang JH. Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic cancer and its prognostic significance. World J Gastrointest Oncol 2025; 17(9): 109055 [PMID: 40977674 DOI: 10.4251/wjgo.v17.i9.109055]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.